Western blotting analysis showed that JMJD1A-knockdown tumours had lower protein levels of JMJD1A and its downstream targets, β-catenin, P-gp and PD-L1, again similar to the IOXL-treated ones (Supplementary Fig. 64). Here, KDM3A is linked to neoplasm.